FDA delays decision on AstraZeneca blood thinner - BusinessWeek

[INCIID News Feed]

Telegraph.co.uk
<img alt="" height="1" width="1" />
FDA delays decision on AstraZeneca blood thinner
BusinessWeek
AstraZeneca said late Thursday the Food and Drug Administration has again extended its review of the experimental blood thinner Brilinta, the second delay this year for one of the company&#39;s potential blockbuster products. Shares of AstraZeneca PLC fell ...
No Green Light For AstraZeneca Blood ThinnerForbes
AstraZeneca blockbuster Brilinta fails to win FDA approvalThe Guardian
FDA Delays Astra&#39;s Key Pipeline Drug BrilintaMorningstar.com
TheHeart.Org -Cardiovascular Business -Wall Street Journal
all 133 news articles &raquo;


More...